Terms: = Cervical cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
40 results:
1. Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
Lin LL; Ndlovu N; Lowenstein J; Wirth M; Lee J; Stier EA; Garg M; Kotzen J; Kadzatsa W; Palefsky J; Krown SE; Einstein MH
Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):439-447. PubMed ID: 36493958
[TBL] [Abstract] [Full Text] [Related]
2. The uterine pathological features associated with sentinel lymph node metastasis in endometrial carcinomas.
Kang Y; Kim TH; Gjertson DW; Cohen JG; Memarzadeh S; Moatamed NA
PLoS One; 2020; 15(11):e0242772. PubMed ID: 33232380
[TBL] [Abstract] [Full Text] [Related]
3. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract] [Full Text] [Related]
4. The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.
Buda A; Casarin J; Mueller M; Fanfani F; Zapardiel I; Mereu L; Puppo A; De Ponti E; Adorni M; Ferrari D; Gasparri ML; Ghezzi F; Scambia G; Papadia A
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1599-1606. PubMed ID: 33130942
[TBL] [Abstract] [Full Text] [Related]
5. cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?
Wenzel HHB; Van Kol KGG; Nijman HW; Lemmens VEPP; Van der Aa MA; Ebisch RMF; Bekkers RLM
Gynecol Oncol; 2020 Aug; 158(2):282-286. PubMed ID: 32381363
[TBL] [Abstract] [Full Text] [Related]
6. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.
Carlson JW; Kauderer J; Hutson A; Carter J; Armer J; Lockwood S; Nolte S; Stewart BR; Wenzel L; Walker J; Fleury A; Bonebrake A; Soper J; Mathews C; Zivanovic O; Richards WE; Tan A; Alberts DS; Barakat RR
Gynecol Oncol; 2020 Feb; 156(2):467-474. PubMed ID: 31837831
[TBL] [Abstract] [Full Text] [Related]
7. Detection of distant metastatic disease by positron emission tomography with
Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
[TBL] [Abstract] [Full Text] [Related]
8. Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists.
Casarin J; Multinu F; Abu-Rustum N; Cibula D; Cliby WA; Ghezzi F; Leitao M; Konishi I; Nam JH; Querleu D; Soliman PT; Yost KJ; Weaver AL; Mariani A; Glaser GE
Int J Gynecol Cancer; 2019 Jan; 29(1):60-67. PubMed ID: 30640685
[TBL] [Abstract] [Full Text] [Related]
9. Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.
Cibula D; Abu-Rustum NR; Fischerova D; Pather S; Lavigne K; Slama J; Alektiar K; Ming-Yin L; Kocian R; Germanova A; Frühauf F; Dostalek L; Dusek L; Narayan K
Gynecol Oncol; 2018 Dec; 151(3):438-443. PubMed ID: 30348519
[TBL] [Abstract] [Full Text] [Related]
10. Evaluating the role of clinical officers in providing reproductive health services in Kenya.
Darwinkel MC; Nduru JM; Nabie RW; Aswani JA
Hum Resour Health; 2018 Jul; 16(1):31. PubMed ID: 29996852
[TBL] [Abstract] [Full Text] [Related]
11. Which Patients With cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
Mahmoud O; Einstein MH
J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Distant Metastatic Disease in Uterine cervical and Endometrial cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Gee MS; Atri M; Bandos AI; Mannel RS; Gold MA; Lee SI
Radiology; 2018 Apr; 287(1):176-184. PubMed ID: 29185901
[TBL] [Abstract] [Full Text] [Related]
13. The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell Carcinoma.
Lee CC; Ho HC; Su YC; Lee MS; Hung SK; Chen YL
Medicine (Baltimore); 2015 Jul; 94(27):e1069. PubMed ID: 26166079
[TBL] [Abstract] [Full Text] [Related]
14. Multifocal FIGO stage 1A1 cervical squamous carcinomas have an extremely good prognosis equivalent to unifocal lesions.
McIlwaine P; Nagar H; McCluggage WG
Int J Gynecol Pathol; 2014 May; 33(3):213-7. PubMed ID: 24681729
[TBL] [Abstract] [Full Text] [Related]
15. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract] [Full Text] [Related]
16. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
Kim CH; Soslow RA; Park KJ; Barber EL; Khoury-Collado F; Barlin JN; Sonoda Y; Hensley ML; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Jun; 23(5):964-70. PubMed ID: 23694985
[TBL] [Abstract] [Full Text] [Related]
17. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Gold MA; Tian C; Whitney CW; Rose PG; Lanciano R
Cancer; 2008 May; 112(9):1954-63. PubMed ID: 18338811
[TBL] [Abstract] [Full Text] [Related]
18. Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer.
Bilde A; von Buchwald C; Therkildsen MH; Mortensen J; Kirkegaard J; Charabi B; Specht L
Laryngoscope; 2008 Mar; 118(3):408-14. PubMed ID: 18043487
[TBL] [Abstract] [Full Text] [Related]
19. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.
Monk BJ; Tian C; Rose PG; Lanciano R
Gynecol Oncol; 2007 May; 105(2):427-33. PubMed ID: 17275889
[TBL] [Abstract] [Full Text] [Related]
20. Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer.
Einstein MH; Novetsky AP; Garg M; Hailpern SM; Huang GS; Glueck A; Fields AL; Kalnicki S; Goldberg GL
Cancer; 2007 Jan; 109(1):48-53. PubMed ID: 17123270
[TBL] [Abstract] [Full Text] [Related]
[Next]
